We are live on ! Find out more
IMA

ImageneBio Inc
IMA

39 hedge funds and large institutions have $26.8M invested in ImageneBio Inc in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 6

7.6% more ownership

Funds ownership: 42.67% → 50.27% (+7.6%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 41 → 39 (-2)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

19% less capital invested

Capital invested by funds: $32.9M → $26.8M (-$6.15M)

Holders
39
Holders Change
-2
Holders Change %
-4.88%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
7
Increased
17
Reduced
6
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$2M
2
BOCH
Blue Owl Capital Holdings
New York
+$880K
3
CCC
Cable Car Capital
California
+$719K
4
Citadel Advisors
Citadel Advisors
Florida
+$246K
5
BCM
BML Capital Management
Indiana
+$154K

Top Sellers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
-$632K
2
Squarepoint
Squarepoint
New York
-$333K
3
DS
DRW Securities
Illinois
-$302K
4
TC
T3 Companies
New York
-$91.1K
5
Millennium Management
Millennium Management
New York
-$79K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$66K -$10.9K -1,686 -11%
PCM
27
Prelude Capital Management
New York
$65K -$3.28K -505 -4%
Goldman Sachs
28
Goldman Sachs
New York
$57.3K +$3.3K +508 +5%
Barclays
29
Barclays
United Kingdom
$54.8K +$1.05K +162 +2%
UBS Group
30
UBS Group
Switzerland
$27.1K +$3.03K +467 +9%
TRCT
31
Tower Research Capital (TRC)
New York
$5.05K +$6.56K +1,011 New
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$5K – – –
VGA
33
Vanguard Global Advisers
Pennsylvania
$3.01K +$3.91K +602 New
JP Morgan Chase
34
JP Morgan Chase
New York
$1.47K +$1.45K +223 +319%
Citigroup
35
Citigroup
New York
$1.12K +$1.45K +224 New
NA
36
NewEdge Advisors
Louisiana
$800 -$2.15K -331 -67%
Wells Fargo
37
Wells Fargo
California
$205 – – –
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$120 – – –
CIAM
39
Caitong International Asset Management
Hong Kong
$10 +$13 +2 New
MIM
40
Monashee Investment Management
Massachusetts
– -$632K -91,621 Closed
Squarepoint
41
Squarepoint
New York
– -$333K -48,237 Closed
DS
42
DRW Securities
Illinois
– -$302K -43,768 Closed
TC
43
T3 Companies
New York
– -$91.1K -13,200 Closed
Millennium Management
44
Millennium Management
New York
– -$79K -11,454 Closed
Bank of America
45
Bank of America
North Carolina
– -$17.9K -2,597 Closed
FFO
46
Fortitude Family Office
Arizona
– -$2.76K -400 Closed
1
2

IMA Hedge Fund Activity: Q1 2026 in Review

39 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2026, worth a combined $26.8M — down 19% from $32.9M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of IMA and 7 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 17 added.

The largest buyer was BVF Inc, adding an estimated $2M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $632K sold.

  • 39 institutional investors held ImageneBio Inc (IMA) as of Q1 2026, down from 41 in Q4 2025.
  • Funds reported $26.8M of ImageneBio Inc stock for Q1 2026, down 19% quarter-over-quarter.
  • 7 funds opened new ImageneBio Inc positions in Q1 2026 and 8 closed out, a net change of -1 holder.
  • The largest ImageneBio Inc buyer in Q1 2026 was BVF Inc, an estimated $2M added.
  • The largest ImageneBio Inc seller in Q1 2026 was Monashee Investment Management, an estimated $632K sold.

Based on aggregated 13F filings for Q1 2026.